Sanjay V Malhotra
Overview
Explore the profile of Sanjay V Malhotra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1032
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inci F, Resendez A, Karaaslan M, Pandrala M, Kojouri A, Ahmed R, et al.
Biosens Bioelectron
. 2025 Jan;
272():117040.
PMID: 39742785
Gastrointestinal (GI) barrier dysfunction is an early pathogenic event in many complex diseases. Despite the routine applications of invasive tests, saccharide molecules are used noninvasively for assessing GI tract mucosal...
2.
Grau B, Kumar P, Nilsen A, V Malhotra S
Org Biomol Chem
. 2024 Dec;
23(7):1479-1532.
PMID: 39623962
The nitrogen-bridgehead is a common structural motif present in a multitude of natural products. As many of these abundant compounds exhibit biological activities, against cancer or bacteria, these derivatives are...
3.
Stefan K, Gordon R, Rolig A, Honkala A, Tailor D, Davis L, et al.
Front Immunol
. 2024 Nov;
15:1450118.
PMID: 39534596
Immunomodulating agents interact with the immune system and alter the outcome of specific immune processes. As our understanding of the immune system continues to evolve, there is a growing effort...
4.
Kumar S, Tailor D, Dheeraj A, Li W, Stefan K, Lee J, et al.
Cell Rep Med
. 2024 Aug;
5(9):101698.
PMID: 39181134
Tumor-associated macrophages (TAMs) and other myelomonocytic cells are implicated in regulating responsiveness to immunotherapies, including immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis. We have developed an ex vivo high-throughput...
5.
Tan Y, Habing K, Riesterer J, Stempinski E, Lewis S, Pfeifer C, et al.
Acta Biomater
. 2024 Aug;
186:95-107.
PMID: 39117115
A goal of regenerative engineering is the rational design of materials to restore the structure-function relationships that drive reparative programs in damaged tissues. Despite the widespread use of extracellular matrices...
6.
Erickson H, Taniguchi S, Raman A, Leitenberger J, V Malhotra S, Oshimori N
Immunity
. 2024 Jul;
57(8):1908-1922.e6.
PMID: 39079535
In squamous cell carcinoma (SCC), macrophages responding to interleukin (IL)-33 create a TGF-β-rich stromal niche that maintains cancer stem cells (CSCs), which evade chemotherapy-induced apoptosis in part via activation of...
7.
Dheeraj A, Marques F, Tailor D, Bermudez A, Resendez A, Pandrala M, et al.
Cell Rep Med
. 2024 May;
5(5):101552.
PMID: 38729158
Y-box binding protein-1 (YB-1) is a proto-oncogenic protein associated with protein translation regulation. It plays a crucial role in the development and progression of triple-negative breast cancer (TNBC). In this...
8.
Ghandadi M, Dobi A, V Malhotra S
Biochim Biophys Acta Rev Cancer
. 2024 Apr;
1879(3):189100.
PMID: 38604268
RIO (right open reading frame) family of kinases including RIOK1, RIOK2 and RIOK3 are known for their role in the ribosomal biogenesis. Dysfunction of RIO kinases have been implicated in...
9.
Tailor D, Garcia-Marques F, Bermudez A, Pitteri S, V Malhotra S
iScience
. 2023 Nov;
26(11):108292.
PMID: 38026225
Guanylate-binding protein 1 (GBP1) is known as an interferon-γ-induced GTPase. Here, we used genetically modified ovarian cancer (OC) cells to study the role of GBP1. The data generated show that...
10.
Savoy L, Long N, Lee H, Chen R, Allen B, Lin H, et al.
Br J Haematol
. 2023 May;
202(1):195-198.
PMID: 37182843
No abstract available.